Poultry Vaccines Market Set to Double to 4.0 Billion by 2033

Trishita Deb
Trishita Deb

Updated · Jul 22, 2024

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Introduction

The Global Poultry Vaccines Market is projected to witness significant growth over the next decade, with its market size anticipated to increase from USD 1.9 billion in 2023 to an estimated USD 4.0 billion by 2033. This growth, occurring at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2033, underscores the rising demand for effective vaccination solutions in the poultry industry.

The market expansion can be attributed to several factors, including increased awareness of poultry health management, advancements in vaccine technology, and the growing prevalence of poultry diseases.

Furthermore, the intensification of poultry farming practices globally necessitates improved disease prevention measures, thereby driving the adoption of vaccines. As the industry continues to evolve, the development of innovative and more effective vaccines will likely play a crucial role in sustaining market growth and ensuring the health and productivity of poultry populations worldwide.

The rising poultry population and the growing prevalence of avian diseases are expected to drive the demand for poultry vaccines. The surge in zoonotic cases is a significant factor contributing to this increased demand. According to a World Health Organization article, there was a 64% rise in zoonotic cases in Africa in 2022. Companies in the poultry vaccine market are increasingly focused on launching innovative technological solutions to strengthen their market position.

Poultry Vaccines Market Size

Key Takeaways

  • Market Size: Poultry Vaccines Market size is expected to be worth around USD 4.0 Billion by 2033 from USD 1.9 Billion in 2023.
  • Market Growth: The market growing at a CAGR of 7.6% during the forecast period from 2024 to 2033.
  • Product Type Analysis: Attenuated Live Vaccines have quickly established themselves as one of the mainstays in the Poultry Vaccines Market, accounting for 31.8% market share.
  • Dosage Form Analysis: growing at a CAGR of 7.6% during the forecast period from 2024 to 2033.
  • Disease Type Analysis: Newcastle Disease dominates the Poultry Vaccines Market with 20.8% market share.
  • Application analysis: Liquid vaccines tailored for breeder applications represent 36.2% of the Poultry Vaccines Market.
  • End-User Analysis: Poultry firms hold an enviable 64% market share in the global Poultry Vaccines Market.
  • Regional Analysis: North America being the leader with 38.7% market share within this niche industry.
  • Drivers: Increased poultry consumption, rising awareness of animal health, and advancements in vaccine technology are major growth drivers.
  • Challenges: High costs of vaccine development and stringent regulatory requirements pose challenges to market growth.
  • Disease Focus: Vaccines targeting Newcastle disease, Marek’s disease, and avian influenza are among the most commonly used.
  • Innovation: Technological advancements, such as recombinant vaccines and vector vaccines, are gaining traction in the market.
  • Market Trends: The adoption of mass vaccination programs and government initiatives to control poultry diseases are key trends.

Poultry Vaccines Statistics

  • Poultry Production: Globally, 73 billion chickens are produced each year.
  • Vaccine Delivery Rates: Only 10% to 20% of vaccines can be administered via subcutaneous or intramuscular injections.
  • Vaccination Coverage: 80% of commercial poultry flocks are vaccinated, essential for disease prevention.
  • Global Implementation: More than 50 countries use vaccination programs to control poultry diseases.
  • System Commercialization: TARGAN system is expected to be commercialized by mid-2023.
  • TARGAN System Efficiency: Achieved a 95% vaccination success rate in trials.
  • Production Loss Due to Diseases: 11% loss in poultry production is due to infectious diseases.
  • Economic Impact: Improved vaccination can save costs and increase production by 11%.
  • Economic Savings: Vaccination programs save the poultry industry $2 billion each year by preventing outbreaks.
  • Agricultural Workforce Training: Over 6,000 young adults trained on health and safety in agriculture.
  • Total Affected Birds (2022-2024): Over 58 million birds were impacted by HPAI, highlighting the virus’s widespread effect.
  • Commercial Flocks: 312 commercial flocks were affected, indicating significant outbreaks in large-scale poultry operations.
  • Backyard Flocks: 432 backyard flocks were impacted across 47 states, showing that small-scale and hobby farms were also severely affected.
  • HPAI Detections (2022-2023): Found in 312 commercial and 432 backyard flocks across 47 states, indicating widespread outbreaks.
  • Birds Affected: Over 58 million birds impacted by HPAI, highlighting extensive damage.
  • Wild Bird Samples: HPAI detected in over 5,900 samples from 49 states, showing the virus’s prevalence in wild birds.
  • Wild Mammal Cases: HPAI identified in 110 cases across 15 species, demonstrating cross-species transmission.
  • Respiratory Exposures: Documented with guidance provided for using PPE in poultry facilities.
  • Agricultural Workforce Training: Over 6,000 young adults trained on health and safety, preparing future agricultural workers.

Global Poultry Vaccines Analysis

  • Total Jobs: The poultry industry supports 2,012,269 jobs across the U.S., showing its significant role in employment.
  • Annual Wages: These jobs contribute $125.6 billion in wages annually, highlighting the industry’s economic importance.
  • Economic Impact: The industry generates $576.6 billion annually, illustrating its extensive economic influence.
  • Tax Contribution: Poultry businesses contribute about $33.7 billion in taxes each year, benefiting public services and infrastructure.
  • Arkansas Poultry Jobs: Provides 157,639 jobs in Arkansas, showing the state’s heavy reliance on this industry.
  • Arkansas Poultry Farms: Over 6,500 farms in Arkansas produce poultry, reflecting the state’s robust farming community.
  • Arkansas Revenue: The industry contributed $5.1 billion in 2021, representing 50% of the state’s agricultural cash receipts.
  • Missouri Poultry Revenue: Generated $1.5 billion in 2021, underlining the industry’s importance to the state economy.
  • Missouri Broiler Contribution: Broilers accounted for $833 million of Missouri’s agricultural receipts, showing their significant role.
  • Oklahoma Broiler Production: Produced over 197 million broilers in 2021, indicating large-scale poultry farming.
  • Oklahoma Revenue: Added $853 million to the state’s agricultural receipts in 2021, reflecting substantial economic contributions.

Emerging Trends

  • Precision Vaccination: Tailored vaccine programs are becoming more popular, focusing on the specific needs of individual flocks based on genetic, health, and environmental factors.
  • Vaccine Development for Emerging Diseases: There’s a continuous effort to develop vaccines for newly emerging pathogens that pose risks to poultry health, ensuring rapid response to outbreaks.
  • Recombinant Vector Vaccines: These vaccines, which use viral or bacterial vectors to deliver antigenic material, are gaining traction due to their ability to induce strong immune responses without the need for live pathogens.
  • Edible Vaccines: Research into vaccines that can be administered through feed is advancing, promising a less stressful method of vaccination for birds.
  • Automation in Vaccine Delivery: Technological advancements are leading to more automated and precise vaccine delivery systems, reducing labor costs and improving vaccine efficacy.
  • Increased Focus on Biosecurity: With global disease outbreaks, there is a heightened focus on biosecurity measures in poultry farming, which includes the strategic use of vaccines.
  • Nano-vaccine Development: Nanotechnology is being explored for developing more effective and stable vaccines that can be stored and transported more easily.
  • Data Integration and Analytics: The use of big data and predictive analytics is improving decision-making in vaccine strategies, predicting outbreaks, and customizing vaccine protocols based on real-time data.
  • Global Health Initiatives: There’s an increasing collaboration between countries on vaccine research and development programs to control transboundary diseases affecting poultry.
  • Environmental Impact Considerations: The environmental impact of vaccine production and administration is becoming a more significant factor in vaccine development and usage strategies.

Use Cases

  • Preventing Disease Transmission: Vaccines are essential in preventing the transmission of contagious diseases like avian influenza, which can devastate poultry populations and affect human health​​.
  • Enhancing Poultry Production: Regular vaccination helps maintain the health of poultry flocks, leading to increased meat and egg production, which is vital for meeting global food demands​​.
  • Economic Benefits: Healthy poultry through effective vaccination contributes to economic stability in the agriculture sector by ensuring consistent production levels and reducing loss due to disease​.
  • Improving Food Safety: Vaccinating poultry reduces the incidence of diseases that can be transmitted to humans through poultry products, thereby enhancing food safety and public health​ (DAU)​.
  • Facilitating International Trade: Countries often require vaccination records for imported poultry to ensure that they are free of specific pathogens, thus facilitating international trade​​.
  • Adhering to Animal Welfare: Vaccination is considered a humane practice as it prevents illness in poultry, aligning with increased consumer demand for ethically produced food​​.
  • Reducing Antibiotic Use: Effective vaccines decrease the necessity for antibiotics in poultry, helping to combat antibiotic resistance a major global health concern​.
  • Long-term Health Management: Some vaccines provide long-term immunity, minimizing the stress of frequent re-vaccination and handling, and promoting the welfare of the birds​.
  • Rapid Response to Emerging Diseases: Modern vaccine technology allows for quick development and deployment against emerging infectious diseases in poultry populations​.
  • Public Health Protection: By controlling diseases in poultry, vaccines play a crucial role in protecting public health, particularly by preventing zoonotic diseases that could spread to humans​.

Conclusion

The Global Poultry Vaccines Market is poised for substantial growth, projected to expand from USD 1.9 billion in 2023 to approximately USD 4.0 billion by 2033, with a CAGR of 7.6%. This growth is driven by heightened awareness of poultry health, technological advancements in vaccines, and increasing incidence of poultry diseases worldwide.

Key trends include the dominance of attenuated live vaccines and the rise of innovations like recombinant and vector vaccines. Despite challenges such as high development costs and regulatory hurdles, the market’s trajectory underscores its critical role in enhancing poultry health and supporting sustainable agricultural practices globally.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Request a Sample Report
We'll get back to you as quickly as possible